KRAS and acute lymphoblastic leukemia: Frequently, in ALL (with a predominance of B lineage), the Ras pathway is activated by somatic mutations of genes that affect regulatory proteins, upstream activators, and pathway components, including NRAS, KRAS, BRAF, FLT3, PTPN11, CBL, and NF1 [55].